Intrinsic Value of S&P & Nasdaq Contact Us

Sagimet Biosciences Inc. SGMT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+44.4%

Stock Statistics — SGMT

Sagimet Biosciences Inc. (SGMT) has a market capitalization of $177.38M and trades at $5.54. The 52-week range is 1.73-11.41.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.5, Earnings Per Share (EPS) of $-1.58.

The stock has a beta of 3.21, operates in the Healthcare sector.

Trading Data
Current Price$5.54
52-Week Range1.73-11.41
Volume448.96K
Avg Volume (30D)521.83K
Market Cap$177.38M
Beta (1Y)3.21
Company
IPO Date2023-07-17
Employees14
CEODavid A. Happel
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS7867001049
CUSIP786700104
Income (Latest Year)
EBITDA$-56.89M
Operating Income$-56.89M
Net Income$-51.04M
EPS$-1.58
EPS Diluted$-1.58
Shares Outstanding$32.35M
Balance Sheet (Latest Year)
Total Assets$116.48M
Current Assets$116.4M
Cash & ST Investments$113.12M
Total Liabilities$5.1M
Total Debt$78K
Net Debt$-34.94M
Total Equity$111.38M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-3.5
P/B Ratio1.59
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message